0000909518-13-000211.txt : 20130924 0000909518-13-000211.hdr.sgml : 20130924 20130924110507 ACCESSION NUMBER: 0000909518-13-000211 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20130924 DATE AS OF CHANGE: 20130924 GROUP MEMBERS: ABAX ARHAT FUND GROUP MEMBERS: ABAX CLAREMONT LTD. GROUP MEMBERS: ABAX GLOBAL CAPITAL GROUP MEMBERS: ABAX GLOBAL CAPITAL (HONG KONG) LTD GROUP MEMBERS: ABAX GLOBAL OPPORTUNITIES FUND GROUP MEMBERS: ABAX LOTUS LTD. GROUP MEMBERS: ABAX UPLAND FUND LLC GROUP MEMBERS: XIANG DONG YANG SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Yongye International, Inc. CENTRAL INDEX KEY: 0001398551 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 208051010 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-84050 FILM NUMBER: 131111453 BUSINESS ADDRESS: STREET 1: 6TH FLR, STE 608 XUE YUAN INT'L TOWER STREET 2: NO. 1 ZHICHUN ROAD,HAIDIAN DISTRICT, CITY: BEIJING, STATE: F4 ZIP: 000000 BUSINESS PHONE: 86-10-8232-8866 MAIL ADDRESS: STREET 1: 6TH FLR, STE 608 XUE YUAN INT'L TOWER STREET 2: NO. 1 ZHICHUN ROAD,HAIDIAN DISTRICT, CITY: BEIJING, STATE: F4 ZIP: 000000 FORMER COMPANY: FORMER CONFORMED NAME: Yongye Biotechnology International, Inc. DATE OF NAME CHANGE: 20080415 FORMER COMPANY: FORMER CONFORMED NAME: Golden Tan, Inc DATE OF NAME CHANGE: 20070504 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Yang Xiang Dong CENTRAL INDEX KEY: 0001439360 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 38 TAI TAM ROAD STREET 2: BLCOK 4, APT.16B CITY: TAI TAM STATE: K3 ZIP: SAR SC 13D/A 1 mm09-2413yi_sc13da5.htm AMENDMENT NO.5 mm09-2413yi_sc13da5.htm

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 
 
SCHEDULE 13D
Under the Securities Exchange Act of 1934
 
(Amendment No. 5)

YONGYE INTERNATIONAL, INC.
(Name of Issuer)
 
 
Common Stock, Par Value $0.001
(Title of Class of Securities)
 
 
98607B106
(CUSIP Number)
 
Richard Yee
Abax Global Capital (Hong Kong) Limited
Two International Finance Centre
Suite 6708, 8 Finance Street, Central
Hong Kong
(852) 3602 1800
 
With copies to:
 
Akiko Mikumo
Weil, Gotshal & Manges, LLP
29/F, Alexandra House
18 Chater Road, Central
Hong Kong
(852) 3476 9000
 
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
 
 
September 23, 2013
(Date of Event Which Requires Filing of this Statement)
 
 
 
 

 
 
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. x
 
 
Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.
 
*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
2

 


CUSIP No.
98607B106
 
 
 
1.
NAME OF REPORTING PERSON:  Abax Lotus Ltd.
 
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)  o
(b)  x
3.
SEC USE ONLY
 
4.
SOURCE OF FUNDS
OO, AF
5.
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEM 2(d) OR 2(e):                                           o
6.
CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7.
SOLE VOTING POWER
0
8.
SHARED VOTING POWER
20,000 (See Item 5)
9.
SOLE DISPOSITIVE POWER
0
10.
SHARED DISPOSITIVE POWER
20,000 (See Item 5)
11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
20,000 (See Item 5)
12.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES                                           o
13.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
Less than 0.1% (See Item 5)
14.
TYPE OF REPORTING PERSON
CO
 

 
 
 

 
3

 


CUSIP No.
98607B106
 
 

1.
NAME OF REPORTING PERSON:  Abax Global Opportunities Fund
 
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)  o
(b)  x
3.
SEC USE ONLY
 
4.
SOURCE OF FUNDS
OO, AF
5.
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEM 2(d) OR 2(e):                                           o
6.
CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7.
SOLE VOTING POWER
0
8.
SHARED VOTING POWER
20,000 (See Item 5)
9.
SOLE DISPOSITIVE POWER
0
10.
SHARED DISPOSITIVE POWER
20,000 (See Item 5)
11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
20,000 (See Item 5)
12.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES                                           o
13.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
Less than 0.1% (See Item 5)
14.
TYPE OF REPORTING PERSON
CO
 
 
 
 
 
 

 
4

 


CUSIP No.
98607B106
 
 

1.
NAME OF REPORTING PERSON:  Abax Upland Fund, LLC
 
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)  o
(b)  x
3.
SEC USE ONLY
 
4.
SOURCE OF FUNDS
OO, AF
5.
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEM 2(d) OR 2(e):                                           o
6.
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7.
SOLE VOTING POWER
0
8.
SHARED VOTING POWER
20,000 (See Item 5)
9.
SOLE DISPOSITIVE POWER
0
10.
SHARED DISPOSITIVE POWER
20,000 (See Item 5)
11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
20,000 (See Item 5)
12.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES                                           o
13.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
Less than 0.1% (See Item 5)
14.
TYPE OF REPORTING PERSON
CO


 
 
 

 
5

 


CUSIP No.
98607B106
 
 

1.
NAME OF REPORTING PERSON:  Abax Arhat Fund
 
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)  o
(b)  x
3.
SEC USE ONLY
 
4.
SOURCE OF FUNDS
OO, AF
5.
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEM 2(d) OR 2(e):                                           o
6.
CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7.
SOLE VOTING POWER
0
8.
SHARED VOTING POWER
20,000 (See Item 5)
9.
SOLE DISPOSITIVE POWER
0
10.
SHARED DISPOSITIVE POWER
20,000 (See Item 5)
11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
20,000 (See Item 5)
12.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES                                           o
13.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
Less than 0.1% (See Item 5)
14.
TYPE OF REPORTING PERSON
CO
 
 

 
 
 

 
6

 


CUSIP No.
98607B106
 
 

1.
NAME OF REPORTING PERSON:  Abax Claremont Ltd.
 
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)  o
(b)  x
3.
SEC USE ONLY
 
4.
SOURCE OF FUNDS
OO, AF
5.
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEM 2(d) OR 2(e):                                           o
6.
CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7.
SOLE VOTING POWER
0
8.
SHARED VOTING POWER
20,000 (See Item 5)
9.
SOLE DISPOSITIVE POWER
0
10.
SHARED DISPOSITIVE POWER
20,000 (See Item 5)
11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
20,000 (See Item 5)
12.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES                                           o
13.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
Less than 0.1% (See Item 5)
14.
TYPE OF REPORTING PERSON
CO



 
 
 

 
7

 


CUSIP No.
98607B106
 
 

1.
NAME OF REPORTING PERSON:  Abax Global Capital
 
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)  o
(b)  x
3.
SEC USE ONLY
 
4.
SOURCE OF FUNDS
OO, AF
5.
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEM 2(d) OR 2(e):                                           o
6.
CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7.
SOLE VOTING POWER
0
8.
SHARED VOTING POWER
20,000 (See Item 5)
9.
SOLE DISPOSITIVE POWER
0
10.
SHARED DISPOSITIVE POWER
20,000 (See Item 5)
11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
20,000 (See Item 5)
12.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES                                           o
13.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
Less than 0.1% (See Item 5)
14.
TYPE OF REPORTING PERSON
CO
 

 

 
 

 
8

 


CUSIP No.
98607B106
 
 
 
1.
NAME OF REPORTING PERSON:  Abax Global Capital (Hong Kong) Limited
 
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)  o
(b)  x
3.
SEC USE ONLY
 
4.
SOURCE OF FUNDS
OO, AF
5.
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEM 2(d) OR 2(e):                                           o
6.
CITIZENSHIP OR PLACE OF ORGANIZATION
Hong Kong
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7.
SOLE VOTING POWER
0
8.
SHARED VOTING POWER
20,000 (See Item 5)
9.
SOLE DISPOSITIVE POWER
0
10.
SHARED DISPOSITIVE POWER
20,000 (See Item 5)
11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
20,000 (See Item 5)
12.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES                                           o
13.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
Less than 0.1% (See Item 5)
14.
TYPE OF REPORTING PERSON
CO



 
 
 

 
9

 


CUSIP No.
98607B106
 
 

1.
NAME OF REPORTING PERSON:  Xiang Dong Yang
 
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)  o
(b)  x
3.
SEC USE ONLY
 
4.
SOURCE OF FUNDS
OO
5.
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEM 2(d) OR 2(e):                                           o
6.
CITIZENSHIP OR PLACE OF ORGANIZATION
Hong Kong
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7.
SOLE VOTING POWER
0
8.
SHARED VOTING POWER
20,000 (See Item 5)
9.
SOLE DISPOSITIVE POWER
0
10.
SHARED DISPOSITIVE POWER
20,000 (See Item 5)
11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
20,000 (See Item 5)
12.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES                                           o
13.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
Less than 0.1% (See Item 5)
14.
TYPE OF REPORTING PERSON
IN



 
10

 



This Amendment No. 5 (this “Amendment”) amends the Schedule 13D filed by Abax Lotus Ltd., a Cayman Islands domiciled exempted company (“Abax Lotus”), Abax Global Opportunities Fund, a Cayman Islands domiciled exempted company (“Global Fund”), Abax Upland Fund LLC, a Delaware limited liability company (“Upland”), Abax Arhat Fund, a Cayman Islands domiciled exempted company (“Arhat”), Abax Claremont Ltd., a Cayman Islands domiciled exempted company (“Abax Claremont”), Abax Global Capital, a Cayman Islands domiciled exempted company (“AGC”), Abax Global Capital (Hong Kong) Limited, a Hong Kong company (“Abax HK”), and Xiang Dong Yang, a citizen of Hong Kong (“Mr. Yang”, together with Abax Lotus, Global Fund, Upland, Arhat, Abax Claremont, AGC and Abax HK, each a “Reporting Person” and together the “Reporting Persons”) on October 19, 2012, as amended by Amendment No. 1 filed on December 31, 2012, Amendment No. 2 filed on April 1, 2013, Amendment No. 3 filed on April 16, 2013 and Amendment No. 4 filed on May 16, 2013 (the “Schedule 13D”). Except as specifically amended by this Amendment, the Schedule 13D remains in full force and effect. Capitalized terms used but not defined in this Amendment have meanings provided in the Schedule 13D.

Item 4.           Purpose of Transaction

Item 4 of the Schedule 13D is hereby amended and supplemented as follows.

The Issuer has announced that it entered into an Agreement and Plan of Merger, dated as of September 23, 2013 (the “Merger Agreement”), with Full Alliance International Limited, Yongye International Limited and Yongye International Merger Sub Limited. The Reporting Persons are not participating in the transactions contemplated by the Merger Agreement. Accordingly, the Consortium Agreement previously entered into among Abax HK, Mr. Wu, Full Alliance and MSPEA was terminated on September 23, 2013. As a result, the Reporting Persons are no longer party to any agreement, arrangement or understanding with respect to securities of the Issuer that could deem them to be in a “group” with Mr. Wu, Full Alliance or MSPEA for purposes of Section 13(d) of the Act. The Reporting Persons do not beneficially own more than 5% of the outstanding shares of Common Stock.

Item 5.           Interest in Securities of the Issuer

Item 5 of the Schedule 13D is hereby amended and restated as follows.

(a)-(b)           The responses of the Reporting Persons to Rows (7) through (13) of the cover pages of this Schedule 13D are incorporated herein by reference.

As of the date hereof, Abax Lotus directly owns 20,000 shares of Common Stock, representing approximately 0.04% of the outstanding shares of Common Stock.

Due to their control relationship over Abax Lotus, each of AGC, Abax Claremont, Arhat, Upland and Global Fund may be deemed to beneficially own (as that term is defined in Rule 13d-3 under the Act) and have shared voting and dispositive power over the shares of Common Stock owned by Abax Lotus. Abax HK is the investment advisor to AGC, Arhat, Upland and Global Fund and therefore may be deemed to beneficially own and have shared voting and dispositive power over the shares of Common Stock owned by Abax Lotus. Due to Mr. Yang’s control relationship over all of these entities, he may therefore be deemed to beneficially own and have shared voting and dispositive power over the shares of Common Stock owned by Abax Lotus. Each of Global Fund, Upland, Arhat,
 
 
 
11

 
 
 
Abax Claremont, AGC, Abax HK and Mr. Yang disclaims beneficial ownership of such shares for all other purposes.

(c)           To the best knowledge of each of the Reporting Persons, none of the Reporting Persons or the Abax Persons has effected any transactions relating to the Common Stock of the Company during the past sixty (60) days.

(d)           Not applicable.

(e)           As disclosed in Item 4 of this Amendment, the Consortium Agreement was terminated on September 23, 2013. The Reporting Persons do not beneficially own more than 5% of the outstanding shares of Common Stock and will not file any further amendments to the Schedule 13D.

Item 6.           Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

Item 6 of the Schedule 13D is hereby amended and supplemented as follows.

As disclosed in Item 4 of this Amendment, the Consortium Agreement was terminated on September 23, 2013. A copy of the termination agreement is attached hereto as an exhibit and is incorporated herein by reference in its entirety.

Item 7.           Material to Be Filed as Exhibits
 
The following is filed herewith as an exhibit to this Amendment:

Exhibit 1
Termination Agreement by and among Mr. Wu, Full Alliance, MSPEA, and Abax HK, dated September 23, 2013.


 
12

 


 

SIGNATURE

 
After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this Amendment is true, complete and correct.
 


Dated: September 24, 2013


 
ABAX LOTUS LTD.
     
     
 
By:
/s/ Xiang Dong Yang
 
Name:
Xiang Dong Yang
 
Title:
Director
   
   
 
ABAX GLOBAL OPPORTUNITIES
FUND
     
     
 
By:
/s/ Xiang Dong Yang
 
Name:
Xiang Dong Yang
 
Title:
Director
     
     
 
ABAX UPLAND FUND, LLC
     
     
 
By:
ABAX CLAREMONT LTD. in its capacity as Managing Member
     
     
 
By:
/s/ Xiang Dong Yang
 
Name:
Xiang Dong Yang
 
Title:
Director
   
   
 
 
 
 
 
 
 
 
 
 
13

 
 
 
 
ABAX ARHAT FUND
 
By:
/s/ Xiang Dong Yang
 
Name:
Xiang Dong Yang
 
Title:
Director
 
 
ABAX CLAREMONT LTD.
     
     
 
By:
/s/ Xiang Dong Yang
 
Name:
Xiang Dong Yang
 
Title:
Director
   
   
 
ABAX GLOBAL CAPITAL
     
     
 
By:
/s/ Xiang Dong Yang
 
Name:
Xiang Dong Yang
 
Title:
Director
 
 
ABAX GLOBAL CAPITAL (HONG
KONG) LIMITED
   
 
By:
/s/ Xiang Dong Yang
 
Name:
Xiang Dong Yang
 
Title:
Director
   
   
 
XIANG DONG YANG
   
   
 
/s/ Xiang Dong Yang
 
Name:
Xiang Dong Yang


 
 
 
 
 
 
 
 
 
 
14
EX-99 2 mm09-2413yi_sc13da5ex1.htm EX.1 - TERMINATION AGREEMENT mm09-2413yi_sc13da5ex1.htm
 
 
EXHIBIT 1
TERMINATION AGREEMENT
 
This TERMINATION AGREEMENT (this “Termination Agreement”), is dated as of September 23, 2013 and is entered into by and among Zishen Wu (“Founder”), Full Alliance International Limited (“Full Alliance”), MSPEA Agriculture Holding Limited (“MSPEA”) and Abax Global Capital (Hong Kong) Limited (“Abax”).  Each of Founder, Full Alliance, MSPEA and Abax is referred to herein as a “Party” and collectively as the “Parties”.  Capitalized terms used but not defined herein shall have the meanings ascribed thereto in the Consortium Agreement (as defined below).
 
RECITALS
 
WHEREAS, the Parties have entered into that certain Consortium Agreement, dated as of October 15, 2012 (the “Consortium Agreement”);
 
WHEREAS, pursuant to Section 8 of the Consortium Agreement, the Parties are permitted to modify the Consortium Agreement; and
 
WHEREAS, the Parties desire to terminate the Consortium Agreement in its entirety on the date hereof.
 
NOW, THEREFORE, the Parties agree as follows:
 
1. Termination of the Consortium Agreement.  The Consortium Agreement is hereby unconditionally and irrevocably terminated in its entirety (including, for the avoidance of doubt, Section 5 thereof) and is of no further force or effect.  As of the date hereof, no Party has any further rights or obligations under the Consortium Agreement.  Each Party agrees that it has no claim arising under or relating to the Consortium Agreement (whether in contract, tort or otherwise) against any other Party.
 
2. Governing Law.  This Termination Agreement and all matters arising out of or relating to this Termination Agreement shall be governed by and construed in accordance with the laws of Hong Kong, without reference to conflict of laws principles.
 
3. No Modification.  No provision in this Termination Agreement can be waived, modified or amended except by written consent of the Parties.
 
4. Counterparts; Entire Agreement.  This Termination Agreement may be signed and delivered by facsimile or portable document format via electronic mail and in one or more counterparts, each of which shall be deemed an original but all of which shall be deemed to constitute a single instrument.  This Termination Agreement sets forth the entire agreement and understanding among the Parties with respect to the subject matter hereof and supersedes all prior agreements, discussions or documents relating thereto.
 
5. Successors.  This Termination Agreement shall inure to the benefit of, and be binding upon, the Parties and their respective successors and assigns.
 

 
[Signatures to Follow on the Next Page]
 

 
 

 

IN WITNESS WHEREOF, the Parties hereto have executed this Termination Agreement as of the date and year first written above.
 
 
Zishen Wu
 
By:
/s/ Zishen Wu
     
   
   
 
Full Alliance International Limited
     
 
By:
/s/ Xingmei Zhong
   
Name:
Xingmei Zhong
   
Title:
Director
   
   
 
MSPEA Agriculture Holding Limited
 
By:
/s/ Samantha Jennifer Cooper
 
 
Name:
Samantha Jennifer Cooper
   
Title:
Director
       
       
 
Abax Global Capital (Hong Kong)
 
Limited
   
 
By:
/s/ Xiang Dong Yang
 
 
Name:
Xiang Dong Yang
   
Title:
Director

 
 
 
 
 
[Signature Page to Termination Agreement]